Ozempic Drug Interactions: Common Medications and What Actually Matters

If you take Ozempic (semaglutide) — or Wegovy, Mounjaro, or Zepbound — the most common medication question is simple: “Can I take my usual pills with it?” The reassuring pharmacology is that GLP-1 (and dual GLP-1/GIP) drugs are peptides. They are broken down by ordinary protein-degrading enzymes (proteolysis), not by the liver's cytochrome P450 (CYP) system that drives most classic drug–drug interactions (Jensen 2017^[1]). So semaglutide and tirzepatide cause remarkably few true pharmacokinetic interactions (Min 2025^[2]). The real-world cautions come from two other directions: GLP-1s slow gastric emptying, which can change how fast some swallowed pills are absorbed (Maselli 2021^[5]), and their shared side effects — nausea, vomiting, diarrhea, reduced fluid intake — can stack with certain drugs to cause real harm. This hub walks through the medications people actually search for: ibuprofen and other NSAIDs, acetaminophen (Tylenol), antibiotics, the pill, insulin and sulfonylureas, metformin, and thyroid medication — honestly and without alarmism.

The core pharmacology: why GLP-1s have few true interactions

Most dangerous drug interactions happen because two drugs compete for the same liver enzyme (usually a CYP enzyme), so one drug raises or lowers the blood level of the other. GLP-1 receptor agonists sidestep this entirely. Semaglutide is a modified peptide that circulates bound to albumin and is eliminated by being chopped up into amino acids and small peptides throughout the body — not by CYP metabolism or kidney/biliary excretion of the intact drug (Jensen 2017^[1]). A comprehensive review of the pharmacokinetics and drug–drug interactions of the approved GLP-1 agonists and the dual GLP-1/GIP agonist tirzepatide concluded that, as a class, they carry a low risk of pharmacokinetic interactions (Min 2025^[2]).

So where do the cautions come from? Two mechanisms, both worth understanding:

• Delayed gastric emptying changes oral-drug timing. GLP-1s slow how fast the stomach empties into the intestine (Maselli 2021^[5]; Dahl 2021^[4]). For a swallowed pill, that can delay or slightly blunt the peak blood level — usually without changing the total amount absorbed. This effect is largest early in treatment and after each dose increase, and it tends to wane as the body adapts.
• Side effects can stack. Nausea, vomiting, diarrhea, and reduced appetite can cause dehydration and electrolyte shifts. Combine that with a drug that itself stresses the kidneys (like an NSAID), lowers blood sugar (like insulin), or that you absorb less of when you are vomiting, and the GLP-1 becomes an indirect contributor to a real problem.

Common OTC painkillers: ibuprofen (NSAIDs) and acetaminophen (Tylenol)

Ibuprofen and other NSAIDs

There is no direct pharmacokinetic interaction between ibuprofen (or naproxen, diclofenac, aspirin, celecoxib) and semaglutide or tirzepatide — one does not change the blood level of the other. The genuine caution is kidney-related and dehydration-driven. NSAIDs reduce blood flow to the kidneys; on their own that is usually well tolerated, but it becomes risky when you are volume-depleted. GLP-1 side effects — vomiting, diarrhea, and simply drinking and eating less — are a common cause of that volume depletion. NSAIDs are also one leg of the so-called “triple whammy” (NSAID + diuretic + ACE inhibitor or ARB), a combination repeatedly shown to raise the risk of acute kidney injury, especially during any dehydrating illness (Calvo 2025^[12]).

Practical translation: occasional ibuprofen for a headache while you are feeling well, eating, and hydrated is generally fine. The situation to avoid is taking NSAIDs during a bout of GLP-1 nausea, vomiting, or diarrhea — precisely when your kidneys are most vulnerable. If you take a blood-pressure medication (especially an ACE inhibitor, ARB, or diuretic), be extra cautious, and reach for acetaminophen instead during GI flare-ups.

Acetaminophen (Tylenol / paracetamol)

Acetaminophen is generally the preferred OTC pain reliever to pair with a GLP-1, because it does not carry the NSAID kidney caution. The one technical wrinkle is absorption timing: because acetaminophen is absorbed in the small intestine, delayed gastric emptying can slow how quickly it reaches peak blood level. In fact, acetaminophen is the classic research probe for measuring gastric emptying. A population pharmacokinetic study co-administering paracetamol (and atorvastatin) with semaglutide found that semaglutide modestly slowed paracetamol absorption (a lower, later peak) without meaningfully reducing the total amount absorbed (Langeskov 2022^[3]). For ordinary pain or fever dosing this is not clinically important — the dose still works; it may just act slightly later if taken right after your injection during early titration.

Antibiotics

There is no known CYP-based interaction between GLP-1 drugs and oral antibiotics — the peptides don't alter antibiotic metabolism. Two practical points apply. First, absorption timing: as with other oral drugs, delayed gastric emptying can slightly slow how fast an oral antibiotic is absorbed; for most antibiotics, where total absorbed dose matters more than a fast peak, this is not clinically significant. Second, and more relevant, is overlapping GI side effects: many antibiotics cause nausea and diarrhea on their own, and GLP-1s do too, so the combination can feel rougher on the gut. If you develop significant vomiting or diarrhea on an antibiotic course while on a GLP-1, watch your hydration and call your prescriber — partly because severe vomiting can reduce how much of any oral drug you actually keep down.

One special case worth flagging: if you take an oral medication where a small change in level genuinely matters — for example, warfarin (where antibiotics themselves can shift INR) — the GLP-1 is not the variable to worry about, but the antibiotic may be, so keep your usual monitoring on schedule. As always, the rule is to tell whoever prescribes the antibiotic that you are on a GLP-1.

Diabetes medications: insulin, sulfonylureas, and metformin

Insulin and sulfonylureas — the one genuinely important interaction

This is the interaction that most deserves the word “caution.” GLP-1 drugs lower blood sugar on their own. When they are added on top of insulin or a sulfonylurea (glipizide, glimepiride, glyburide) — medications that can drive glucose down regardless of how high it is — the combined glucose-lowering effect can cause hypoglycemia (low blood sugar). This is a well-established, expected pharmacodynamic interaction, not a quirky one. Major guidelines specifically advise that when a GLP-1 is added, the dose of insulin or sulfonylurea often needs to be reduced to avoid lows (Inzucchi 2012^[14]). In the STEP-2 trial of semaglutide in people with type 2 diabetes, hypoglycemia risk was concentrated in those also taking sulfonylureas, underscoring the point (Davies 2021^[9]).

Metformin — commonly combined, and fine

Metformin is one of the most common companions to a GLP-1 and the pairing is well established and safe. Metformin by itself does not cause hypoglycemia, so adding a GLP-1 does not create the insulin/sulfonylurea problem above. The two are routinely used together in pivotal trials — for example, SURPASS-2 compared tirzepatide and semaglutide in people whose background therapy was metformin (Frías 2021^[10]). The main thing the two share is GI side effects (nausea, diarrhea), so starting both at once, or escalating both quickly, can be harder on the gut — a reason clinicians often stagger dose increases rather than a true interaction. Our tirzepatide + metformin combination guide covers this pairing in depth.

Other common medications: thyroid, the pill, and oral drugs that matter

Levothyroxine (thyroid hormone) — a timing nuance

Levothyroxine (Synthroid) is absorbed in the upper small intestine and is sensitive to anything that alters gastric handling, so the gastric-emptying effect of a GLP-1 is theoretically relevant to how fast it is absorbed. There is no CYP interaction, and most people on stable thyroid replacement do fine, but because thyroid dosing is finely tuned, it is sensible to keep your levothyroxine routine consistent (same time, on an empty stomach) and have thyroid labs (TSH) rechecked after starting a GLP-1 so the dose can be adjusted if needed. We cover this specific pairing in detail in our GLP-1 and levothyroxine guide.

Birth control (oral contraceptives)

For semaglutide, the evidence is reassuring: a dedicated study showed semaglutide does not reduce the bioavailability of a combined ethinylestradiol/levonorgestrel oral contraceptive (Kapitza 2015^[6]), and an oral-semaglutide study likewise found no clinically relevant effect on contraceptive PK (Jordy 2021^[7]). For tirzepatide, however, there is a real, label-specified caution: because of its stronger early effect on gastric emptying, tirzepatide can reduce oral-contraceptive absorption around dose initiation/escalation, and the manufacturer advises adding a barrier method or switching to a non-oral contraceptive for a period after starting or increasing the dose. This is one of the few class differences that genuinely matters — we cover it fully in our GLP-1 and birth control guide.

Narrow-therapeutic-index oral drugs in general

For most oral medications, a slightly slower or later peak from delayed gastric emptying doesn't matter. Studies of liraglutide across different drug classes found only minor, clinically unimportant absorption changes for most oral drugs (Malm-Erjefält 2015^[8]), and semaglutide co-administration studies of furosemide and rosuvastatin showed no clinically relevant PK changes (Jordy 2021^[7]). The drugs to simply be aware of are those where a precise, steady level matters — thyroid hormone, certain seizure medications, and warfarin — not because the GLP-1 chemically interferes, but because consistency and routine monitoring keep them safe. Flag these to your prescriber so monitoring stays on schedule.

Interactions we cover in depth elsewhere

Several specific pairings have their own dedicated, fully-cited articles. Here is the one-line summary of each, with a link to the detail:

• Alcohol: no chemical interaction, but GLP-1s can amplify nausea, reduce alcohol's appeal, and add to dehydration — see Ozempic and alcohol.
• Caffeine / coffee: no true interaction; the overlap is GI — coffee and GLP-1 nausea/reflux can compound — see Ozempic and caffeine.
• Cannabis (weed): no PK interaction; the practical issues are appetite and GI effects — see Ozempic and cannabis.
• Statins (rosuvastatin, atorvastatin): co-administration studies show no clinically meaningful PK change — see GLP-1 and statins.
• PDE5 inhibitors (sildenafil/Viagra, tadalafil/Cialis): no direct interaction — see GLP-1 and sildenafil/tadalafil.
• Levothyroxine (thyroid): timing/absorption nuance, recheck TSH — see GLP-1 and levothyroxine.
• Birth control: reassuring for semaglutide; real barrier-method caution for tirzepatide — see GLP-1 and birth control.
• General side-effect questions: our GLP-1 side-effect Q&A answers the most-asked safety questions.

The general rule: always tell your prescriber and pharmacist

Because the few real cautions are about context (kidney stress during dehydration, hypoglycemia with insulin/sulfonylureas, absorption timing for finely-tuned drugs) rather than fixed chemical clashes, the single most useful habit is a complete, current medication list — prescriptions, OTC products, and supplements — shared with whoever manages your GLP-1 and with your pharmacist. GLP-1s are also increasingly co-prescribed with cardiovascular and metabolic medications in people who, by definition, take several drugs (SELECT enrolled adults with established cardiovascular disease, Lincoff 2023^[13]), so a clear picture of your full regimen lets your team adjust doses (especially diabetes drugs) and time medications sensibly. When in doubt about any specific pill, ask your pharmacist — it takes a minute and catches the rare combination that matters.

Bottom line

• GLP-1 drugs (semaglutide, tirzepatide) are peptides cleared by proteolysis, not CYP enzymes, so they cause very few true pharmacokinetic interactions (Jensen 2017^[1]; Min 2025^[2]).
• The real cautions come from delayed gastric emptying (which can slow oral-drug absorption timing) and from stacking side effects (nausea, vomiting, dehydration).
• Ibuprofen/NSAIDs: no direct interaction, but avoid during GI flare-ups — dehydration + NSAIDs stress the kidneys, especially with diuretics/ACE/ARB (Calvo 2025^[12]). Acetaminophen is generally the safer OTC choice (Langeskov 2022^[3]).
• Insulin and sulfonylureas: the one important interaction — added glucose-lowering can cause hypoglycemia; doses usually need reducing (Inzucchi 2012^[14]; Davies 2021^[9]). Metformin is commonly combined and fine (Frías 2021^[10]).
• Birth control is reassuring for semaglutide (Kapitza 2015^[6]) but carries a real barrier-method caution for tirzepatide; levothyroxine is a timing nuance — recheck TSH.
• When in doubt, tell your prescriber and pharmacist your full medication list — the cautions are about context, not fixed clashes.

Related research

• GLP-1 side-effect questions answered — the most-asked safety questions, fully cited.
• Tirzepatide + metformin combination — the most common diabetes pairing.
• GLP-1 and birth control — the semaglutide-vs-tirzepatide contraceptive difference.
• GLP-1 and levothyroxine — thyroid-hormone absorption and TSH monitoring.

Important disclaimer. This article is educational and does not constitute medical advice. Do not start, stop, or adjust any medication — including insulin, sulfonylureas, or over-the-counter painkillers — without consulting your prescriber. Drug interactions depend on your individual health, kidney function, and full medication list; always share that list with your prescriber and pharmacist. Every primary source cited here was verified against the live PubMed E-utilities API on 2026-06-19.